What are the implications for clinical management and service development of prevalent comorbidity in UK mental health and substance misuse treatment populations?

Drugs: Education, Prevention and Policy

Volumn 11, Issue 4, 2004, Pages 329-348

  Weaver, Tim ^a   Stimson, Gerry ^a   Tyrer, Peter ^a   Barnes, Thomas ^a   Renton, Adrian ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4444250753     PISSN: 09687637     EISSN: None     Source Type: Journal    
DOI: 10.1080/09687630410001687851     Document Type: Review

References (42)

1. APPLEBY, L., SHAW, J., AMOS, T. et al. (1999). Suicide within 12 months of contact with mental health services: national clinical survey. British Medical Journal, 318, 1235-1239.
2. ÅSBERG, M., MONTGOMERY, S., PERRIS, C. et al. (1978). A comprehensive psychopathological rating scale. Acta Psychiatrica Scandinavica, 271(Suppl.), 5-27.
3. BANERJEE, S., CLANCY, C. & CROME, I. (Eds) (2002). Co-existing Problems of Mental Disorder and Substance Misuse (Dual Diagnosis): an information manual. London: The Royal College of Psychiatrists' Research Unit.
4. BARROWCLOUGH, C., HADDOCK, G., TARRIER, N. et al (2001). Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry, 158, 1706-13.
5. BROONER, R.K., KING, V.L, KIDORF, M. et al. (1997). Psychiatric and substance misuse comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry, 54, 71-80.
6. CAREY, M.P., CAREY, K.B. & MEISLER, A.W. (1991). Psychiatric symptoms in mentally ill chemical abusers. Journal of Nervous and Mental Disease, 179, 136-138.
7. DEPARTMENT OF HEALTH (1998). Modernising Mental Health Services. London: Department of Health.
8. DEPARTMENT OF HEALTH (2002). Mental Health Policy Implementation Guide: dual diagnosis good practice guide. London: Department of Health.
9. DEPARTMENT OF HEALTH AND HUMAN SERVICES (1999). Mental Health: A report of the Surgeon General. Rockville, MD, USA: Department of Health and Human Services, National Institute of Mental Health.
10. DRAKE, R.E., MERCER-MCFADDEN, C., MUESER, K.T. et al. (1998). Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin, 24, 589-608.
11. DRIESSEN, M., VELTRUP, C., WEBER, J. et al. (1998). Psychiatric comorbidity, suicidal behaviour and suicidal ideation in alcoholics seeking treatment. Addiction, 93, 889-894.
12. DUKE, P.J., PANTELIS, C., MCPHILLIPS, M.A. & BARNES, T.R.E. (2001). Comorbid substance misuse among people with schizophrenia in the community: an epidemiological study in central London. British Journal of Psychiatry, 179, 501-513.
13. GOSSOP, M., DARKE, S., GRIFFITHS, P. et al. (1995). The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90, 607-614.
14. HALL, W. & FARRELL, M. (1997). Comorbidity of mental disorders with substance misuse. British Journal of Psychiatry, 171, 4-5.
15. HAYWOOD, T.W., KRAVITZ, H.M., GROSSMAN, L.S. et al. (1995). Predicting the 'revolving door' phenomenon among patients with schizophrenic, schizoaffective and affective disorders. American Journal of Psychiatry, 152, 856-61.
16. HUNT, G.E., BERGEN, J. & BASHIR, M. (2002). Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophrenia Research, 54, 253-264.
17. JOHNSON, S. (1997). Dual diagnosis of severe mental illness and substance misuse: a case for specialist services? British Journal of Psychiatry, 171, 205-208.
18. KESSLER, R.C., MCGONAGLE, K.A., ZHAO, S. et al. (1994). Lifetime and 12 month prevalence of DSM-III-R psychiatric disorders in the United States: results from the national comorbidity survey. Archives of General Psychiatry, 51, 8-19.
19. LEY, A., JEFFERY, D.P., MCLAREN, S. & SIEGFRIED, N. (1999). Treatment programmes for people with both severe mental illness and substance misuse (Cochrane Review). In: The Cochrane Library Issue 2. Oxford: Update Software.
20. MCGUFFIN, P., FARMER, A.E. & HARVEY, I. (1991). A polydiagnostic application of operational criteria in studies of psychotic: illness: development and reliability of the OPCRIT system. Archives of General Psychiatry, 48, 764-770.
21. MENEZES, P.R., JOHNSON, S., THORNICROFT, G. et al. (1996). Drug and alcohol problems among individuals with severe mental illness in South London. British Journal of Psychiatry, 168, 612-619.
22. MINER, C.R., ROSENTHAL, R.N., HELLERSTEIN, D.J. & MUENZ, L.R. (1997). Prediction of compliance with outpatient referral in patients with schizophrenia and psychoactive substance use disorders. Archives of General Psychiatry, 54, 706-712.
23. MONTGOMERY, S.A. & ÅSBERG, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382-389.
24. MUESER, K.T., BELLACK, A.S. & BLANCHARD, J.J. (1997). Comorbidity of schizophrenia and substance abuse: implications for treatment. In G.A. Marlatt & G.G. VandenBos (eds), Addictive behaviors: readings on etiology, prevention, and treatment. New York: Pergamon Press.
25. NATIONAL TREATMENT AGENCY FOR SUBSTANCE MISUSE (2002). Models of Care for the Treatment of Drug Misusers. London: National Treatment Agency for Substance Misuse.
26. PHELAN, M., SLADE, M., THORNICROFT, G. et al. (1995). The Camberwell Assessment of Need: the validity & reliability of an instrument to assess the needs of people with severe mental illness. British Journal of Psychiatry, 167, 589-595.
27. REGIER, D.A., FARMER, M.E., RAE, D.S. et al. (1990). Comorbidity of mental disorder with alcohol and other drug abuse: results from an epidemiological catchment area (ECA) study. Journal of the American Medical Association, 264, 2511-2518.
28. ROTH, A & FONARGY, P. (1996) What works for whom? A critical review of psychotherapy research. London: Guilford Press.
29. SANDFORD, T. (1995). Drug use is increasing. Nursing Times, 9, 16.
30. SAUNDERS, J.B., AASLAND, O.G., BABOR, T.F. et al. (1993). Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addiction, 88, 791-804.
31. SCOTT, H., JOHNSON, P., MENEZES, P. et al. (1998). Substance misuse and risk of aggression and offending among the severely mentally ill. British Journal of Psychiatry, 172, 345-350.
32. SPSS (1999). SPSS for Windows, Version 10.0.5. Chicago, IL: SPSS, Inc.
33. SWARTZ, M.S., SWANSON, J.W., HIDAY, V.A. et al. (1998). Violence and severe mental illness: the effects of substance abuse and non-adherence to medication. American Journal of Psychiatry, 155, 226-231.
34. TYRER, P. (2000). Quick Personality Assessment Schedule: PAS-Q. In P. Tyrer (ed.), Personality disorders: diagnosis, management and course, 2nd edn, (pp. 181-190). London: Edward Arnold.
35. TYRER, P., OWEN, R.T. & CICCHETTI, D.V. (1984). The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale. Journal of Neurology, Neurosurgery, and Psychiatry, 47, 970-975.
36. WAGNER, E.H. & SIMON, G.E. (2001). Managing depression in primary care. British Medical Journal, 322, 746-747.
37. WEAVER, T., RENTON, A., STIMSON, G. & TYRER, P. (1999). Severe mental illness and substance misuse comorbidity: research is needed to inform policy and service development. British Medical Journal, 318, 37-8.
38. WEAVER, T., HICKMAN, M., RUTTER, D. et al. (2001). The prevalence and management of mental illness and substance misuse comorbidity in current mental health and substance misuse treatment populations. Drug and Alcohol Review, 20, 407-416.
39. WEAVER, T., MADDEN, P., CHARLES, V., STIMSON, G., RENTON, A., TYRER, P., BARNES, T., BENCH, C., MIDDLETON, H., WRIGHT, N., PATERSON, S., SHANAHAN, W., SEIVEWRIGHT, N. & FORD, C. (2003). Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. British Journal of Psychiatry, 183, 304-313.
40. WILLIAMS, K. (1999). Attitudes of mental health professionals to comorbidity between mental health problems and substance misuse. Journal of Mental Health, 8, 605-613.
41. WRIGHT, S., GOURNAY, K., GLORNEY, E. & THORNICROFT, G. (2000). Dual diagnosis in the suburbs: prevalence, need and in-patient service use. Social Psychiatry & Psychiatric Epidemiology, 35, 297-304.
42. ZIEDONIS, D. & TRUDEAU, K. (1997) Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model. Schizophrenia Bulletin, 23, 229-238.